Stable non-cystic fibrosis bronchiectasis is associated with deficiency of the pattern recognition molecule L-Ficolin

J. Chalmers, S. MacDonald, A. Mohammed, M. Murray, S. Hart, D. Kilpatrick, A. Hill (Edinburgh, United Kingdom)

Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Session: Microbiology and treatment of bronchiectasis and exacerbations of COPD
Session type: E-Communication Session
Number: 274
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Chalmers, S. MacDonald, A. Mohammed, M. Murray, S. Hart, D. Kilpatrick, A. Hill (Edinburgh, United Kingdom). Stable non-cystic fibrosis bronchiectasis is associated with deficiency of the pattern recognition molecule L-Ficolin. Eur Respir J 2008; 32: Suppl. 52, 274

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Mannose binding lectin deficiency is associated with disease severity in patients with non-cystic fibrosis bronchiectasis
Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis
Year: 2011

Lung function in non-cystic fibrosis bronchiectasis – determinant factors
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019

Aetiology of non cystic fibrosis bronchiectasis and its correlation with the site of pulmonary damage
Source: Eur Respir J 2003; 22: Suppl. 45, 504s
Year: 2003

Nasal potential difference of carriers of the W493R ENaC variant with non-cystic fibrosis bronchiectasis
Source: Eur Respir J 2016; 47: 322-324
Year: 2016


CXCR4+ granulocytes reflect fungal cystic fibrosis lung disease
Source: Eur Respir J 2015; 46: 395-404
Year: 2015



LATE-BREAKING ABSTRACT: A relative plasma Elafin deficiency in children with cystic fibrosis (CF) is associated with pulmonary disease
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014

Serum levels of surfactant proteins in patients with combined pulmonary fibrosis and emphysema (CPFE)
Source: International Congress 2015 – IPF pathogenesis
Year: 2015



Phenotype characterization of non-cystic fibrosis bronchiectasis in India.
Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Year: 2017

Increased epithelial production of LPLUNC1 in cystic fibrosis lung disease
Source: Annual Congress 2011 - Epithelial cell biology
Year: 2011


Sputum neutrophils are related to functional status in non-cystic fibrosis bronchiectasis
Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas
Year: 2010

Increased systemic inflammation in cystic fibrosis (CF) is associated with deterioration in lung clearance index (LCI)
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014

Serum surfactant protein D (SP-D) and annual decline of diffusion capacity are prognostic factors for combined pulmonary fibrosis with emphysema (CPFE) in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases
Year: 2013


The lung clearance index correlates with markers of pulmonary deterioration in patients with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013

MRI detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014

Identification of a new cystic fibrosis transmembrane regulator mutation in a severely affected patient
Source: Eur Respir J 2002; 19: 374-376
Year: 2002



Dysregulation of the expression and activity of antimicrobial peptides in COPD and cystic fibrosis
Source: International Congress 2018 – Antimicrobial host defence and innate immunity in the lung
Year: 2018


The lung epithelium is a prominent source of Wnt ligands and inhibitors in idiopathic pulmonary fibrosis
Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon
Year: 2008

Plasma protein signature of idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013

Molecular detection of complex microbial communities in sputa of patients with cystic fibrosis and non cystic fibrosis bronchiectasis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Year: 2010

The lung microbiome in chronic suppurative lung disease: cystic fibrosis and non-cystic fibrosis bronchiectasis
Source: Eur Respir Monogr 2019; 83: 158-172
Year: 2019